Vaccine distribution planned on UC campus
State's expanded COVID-19 vaccine distributon to include Ohio campuses
In an afternoon press conference held Thursday, Ohio Governor Mike DeWine announced that medical providers will soon receive delivery of COVID-19 vaccine in order to administer the vaccine to university students in Ohio. Students will be eligible to receive these designated supplies on a voluntary basis.
University of Cincinnati students are encouraged to make use of this on-campus opportunity to obtain the one-dose Johnson & Johnson, starting on April 10. The one-dose provides simple, one-time administration – no follow-up second dose weeks later. This is especially convenient for those students who are planning to leave the area and/or won’t be on campus after spring term comes to a close.
Due to national supply limitations, UC's on-campus vaccination clinic will be one of the few sources of single-dose vaccine in southwest Ohio, and we anticipate ultimately having enough vaccine to vaccinate all students wishing to do so before the end of the semester.
Vaccination clinics will begin Saturday, April 10.
- Visit the vaccine page of UC's Public Health website for updated information on planning and expected timeline.
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.
Combination immunotherapy helps overcome melanoma treatment resistance
November 10, 2025
MSN highlighted research led by the University of Cincinnati Cancer Center's Trisha Wise-Draper showing a combination of immunotherapy medications can activate a robust immune response and help overcome treatment resistance in patients with refractory melanoma.